HPEBP4 as a predictive marker for the pathological response of rectal cancer to preoperative radiotherapy

International Journal of Colorectal Disease

Volumn 28, Issue 2, 2013, Pages 241-246

  Qiu, Jianming ^a   Yang, Guangen ^a   Shen, Zhong ^a   Xie, Ya ^a   Wang, Lewei ^a  

^a THE THIRD PEOPLE S HOSPITAL OF HANGZHOU   (China)

Author keywords

Human phosphatidylethanolamine binding protein 4; Predictive marker; Preoperative radiotherapy; Rectal cancer

Indexed keywords

HUMAN PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN 4; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL EVALUATION; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PREOPERATIVE RADIOTHERAPY; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RADIOSENSITIVITY; RECTUM CANCER; RETROSPECTIVE STUDY; SEX DIFFERENCE; TREATMENT OUTCOME; TUMOR BIOPSY; UPREGULATION;

DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PREOPERATIVE CARE; PROGNOSIS; RADIATION TOLERANCE; RECTAL NEOPLASMS; REGRESSION ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84879492437     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1534-3     Document Type: Article

References (33)

1. Janjan NA, Khoo VS, Abbruzzese J et al (1999) Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M.D. Anderson cancer center experience. Int J Radiat Oncol Biol Phys 44:1027-1038
2. Theodoropoulos G, Wise WE, Padmanabhan A et al (2002) T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 45:895-903
3. Kaminsky-Forrett MC, Conroy T, Luporsi E et al (1998) Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys 42:935-941
4. Chan AK, Wong AO, Langevin J et al (2000) Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study. Int J Radiat Oncol Biol Phys 48:843-856
5. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B (2005) Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol 23:8697-8705
6. Stelzmueller I, Zitt M, Aigner F et al (2009) Postoperative morbidity following chemoradiation for locally advanced low rectal cancer. J Gastrointest Surg 13:657-667
7. Lin LC, Lee HH, Hwang WS et al (2006) p53 and p27 as predictors of clinical outcome for rectal-cancer patients receiving neoadjuvant therapy. Surg Oncol 15:211-216
8. Kuremsky JG, Tepper JE, McLeod HL (2009) Biomarkers for response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 74:673-688
9. Lenart P, Petronczki M, Steegmaier M, Di FB, Lipp JJ, Hoffmann M, Rettig WJ, Kraut N, Peters JM (2007) The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of Polo-like kinase 1. Curr Biol 17:304-315
10. Steegmaier M, Hoffmann M, Baum A, Lenart P, Petronczki M, Krssak M, Gurtler U, Garin-Chesa P, Lieb S, Quant J, Grauert M, Adolf GR, Kraut N, Peters JM, Rettig WJ (2007) BI 2536, a potent and selective inhibitor of Polo-like kinase 1, inhibits tumor growth in vivo. Curr Biol 17:316-322
11. Gumireddy K, Reddy MV, Cosenza SC, Boominathan R, Baker SJ, Papathi N, Jiang J, Holland J, Reddy EP (2005) ON01910, a non-ATP-competitive small molecule inhibitor of PLK1, is a potent anticancer agent. Cancer Cell 7:275-286
12. McInnes C, Mezna M, Fischer PM (2005) Progress in the discovery of Polo-like kinase inhibitors. Curr Top Med Chem 5:181-197
13. Gilmartin AG, Bleam MR, Richter MC, Erskine SG, Kruger RG, Madden L, Hassler DF, Smith GK, Gontarek RR, Courtney MP, Sutton D, Diamond MA, Jackson JR, Laquerre SG (2009) Distinct concentration dependent effects of the Polo-like kinase 1-specific inhibitor GSK461364A, including differential effect on apoptosis. Cancer Res 69:6969-6977
14. Wang X, Li N, Liu B et al (2004) A novel human phosphatidylethanolamine- binding protein resists TNF-α-induced apoptosis by inhibiting mitogen-activated protein kinase pathway activation and phosphatidylethanolamine externalization. J Biol Chem 279:45855-45864
15. Wang X, Li N, Li H et al (2005) Silencing of human phosphatidylethanolamine-binding protein 4 sensitizes breast cancer cells to TNF-α-induced apoptosis and cell growth arrest. Clin Cancer Res 11:7545-7553
16. Li H, Wang X, Li N et al (2007) hPEBP4 resists TRAIL-induced apoptosis of human prostate cancer cells by activating Akt and deactivating ERK1/2 pathways. J Biol Chem 282:4943-4950
17. Li P, Wang X, Li N et al (2006) Anti-apoptotic hPEBP4 silencing promotes TRAIL-induced apoptosis of human ovarian cancer cells by activating ERK and JNK pathways. Int J Mol Med 18:505-510
18. Zhang Y, Wang X, Xiang Z et al (2007) Promotion of cellular migration and apoptosis resistance by a mouse eye-specific phosphatidylethanolamine-binding protein. Int J Mol Med 19:55-63
19. Gogineni VR, Kargiotis O, Klopfenstein JD et al (2009) RNAi-mediated downregulation of radiation-induced MMP-9 leads to apoptosis via activation of ERK and Akt in IOMM-Lee cells. Int J Oncol 34(1):209-218
20. Corn BW, Kovner F, Bek S et al (2008) ERK signaling in colorectal cancer: a preliminary report on the expression of phosphorylated ERK and the effects of radiation therapy. Am J Clin Oncol 31(3):255-258
21. Kang YH, Lee SJ (2008) Role of p38 MAPK and JNK in enhanced cervical cancer cell killing by the combination of arsenic trioxide and ionizing radiation. Oncol Rep 20(3):637-643
22. Wang Y, Liu L, Zhou D (2011) Inhibition of p38 MAPK attenuates ionizing radiation-induced hematopoietic cell senescence and residual bone marrow injury. Radiat Res 176(6):743-752
23. Ho SY, Wu WJ, Chiu HW et al (2011) Arsenic trioxide and radiation enhance apoptotic effects in HL-60 cells through increased ROS generation and regulation of JNK and p38 MAPK signaling pathways. Chem Biol Interact 193(2):162-171
24. Nix P, Cawkwell L, Patmore H et al (2005) Bcl-2 expression predicts radiotherapy failure in laryngeal cancer. Br J Cancer 92:2185-2189
25. del Franz Ro, Sarah Keppner, Gianni Capalbo et al (2010) Polo-like kinase 1 as predictive marker and therapeutic target for radiotherapy in rectal cancer. Am J Pathol 27:918-929
26. Dworak O, Keilholz L, Hoffmann A (1997) Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12:19-23
27. Perez RO (2011) Predicting response to neoadjuvant treatment for rectal cancer: a step toward individualized medicine. Dis Colon Rectum 54(9):1057-1058
28. Shioya M, Takahashi T, Ishikawa H et al (2011) Expression of hypoxia-inducible factor 1α predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer. J Cancer Res Clin Oncol J Radiat Res 52(6):821-827
29. Shinto E, Hashiguchi Y, Ueno H et al (2011) Pretreatment CD133 and cyclooxygenase-2 expression as the predictive markers of the pathological effect of chemoradiotherapy in rectal cancer patients. Dis Colon Rectum 54(9):1098-1106
30. Kim K, Chie EK, Wu HG et al (2011) High surviving expression as a predictor of poor response to preoperative chemoradiotherapy in locally advanced rectal cancer. Int J Colorectal Dis 26(8):1019-1023
31. Improved survival with preoperative radiotherapy in resectable rectal cancer Swedish Rectal Cancer Trial (1997) N Engl J Med 336:980-987
32. Meyn RE, Milas L, Ang KK (2009) The role of apoptosis in radiation oncology. Int J Radiat Biol 85:107-115
33. Yang JY, Xia W, Hu MC (2006) Ionizing radiation activates expression of FOXO3a, Fas ligand, and Bim, and induces cell apoptosis. Int J Oncol 29:643-648